| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/27/2001 | WO2001070974A1 Novel protein, process for producing the same and use thereof |
| 09/27/2001 | WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070769A1 Peptide derivative |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070754A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070753A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 09/27/2001 | WO2001070723A1 Benzothiophene derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070709A2 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity |
| 09/27/2001 | WO2001070708A1 Substituted piperidines as melanocortin receptor agonists |
| 09/27/2001 | WO2001070700A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/27/2001 | WO2001070698A1 Quinoline derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070694A1 Amorphous torasemide modification |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | WO2001070662A2 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 09/27/2001 | WO2001070591A1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/27/2001 | WO2001070337A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 09/27/2001 | WO2001070278A1 IMPROVED SOLUBILITY AND DISPERSIBILITY BY EXPOSURE TO O¿x? |
| 09/27/2001 | WO2001070254A1 Use of human not1 and not1a orphan receptors |
| 09/27/2001 | WO2001070219A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 09/27/2001 | WO2001070208A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 09/27/2001 | WO2001070130A2 Compositions derived from modiolus modiolus and methods for making and using same |
| 09/27/2001 | WO2001062705A8 Aminoalcohol derivatives |
| 09/27/2001 | WO2001032663A3 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/27/2001 | WO2001032654A3 Novel heterocyclic compounds and their use as medicines |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001019829A3 Pyrazolopyrimidines as therapeutic agents |
| 09/27/2001 | WO2001012606B1 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 09/27/2001 | WO2001012127B1 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | WO2001001968A3 Methods and compositions for regulating gut motility and food intake |
| 09/27/2001 | WO2000057837A8 Compositions and methods for effecting the levels of cholesterol |
| 09/27/2001 | US20010025113 Nutrients, foods, drugs |
| 09/27/2001 | US20010025108 Thrombosis diseases |
| 09/27/2001 | US20010025057 Containing nitric oxide donar containing nitroglycerin, glycol dinitrate, isopropyl nitrate, glyceryl-1,3-dinitrate, glyceryl-1,2-dinitrate, butane-1,2,4-triol-trinitrate, erythrityl teteranitrate, pentaerithrityl tetetranitrate etc. |
| 09/27/2001 | US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives |
| 09/27/2001 | US20010025044 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 09/27/2001 | US20010025039 Tricyclic aza-indolyl derivatives substituted with ethylamine group is useful for treating central nervous system disorder,cardiovascular disorder, gastrointestinal disorders, diabetes insipidus, and particularly useful for obesity |
| 09/27/2001 | US20010025036 Modifying the structure of a 1alpha-hydroxylated vitamin D compound to increase its in vivo activity by altering the conformational equilibrium of the A-ring to favor a chair conformation that presents 1alphahydroxy in axial orientation |
| 09/27/2001 | US20010025026 Chimeric proteins for use in transport of a selected substance into cells |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024792 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
| 09/27/2001 | US20010024786 Purified polypeptide of given sequence; useful in diagnosis, prevention, and treatment of cancer, inflammation, and disorders of fatty acid metabolism |
| 09/27/2001 | US20010024666 Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 09/27/2001 | US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants |
| 09/27/2001 | US20010024659 Controlled release metformin formulations |
| 09/27/2001 | US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release |
| 09/27/2001 | US20010024642 A chewing gum that includes a gum center and a coating that substantially surrounds the center, comprises at least 50% by weight of chewing gum, the coating includes medicine; chewing the gum, causes the drug release, in patients buccal cavity |
| 09/27/2001 | CA2689798A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404226A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 09/27/2001 | CA2403828A1 Inhibitors of p38 |
| 09/27/2001 | CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | CA2403815A1 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | CA2403805A1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | CA2403671A1 Compositions derived from modiolus modiolus and methods for making and using same |
| 09/27/2001 | CA2403631A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403553A1 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | CA2403486A1 Talaromyces emersonii beta-glucanases |
| 09/27/2001 | CA2403447A1 Peptide derivative |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402572A1 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity |
| 09/27/2001 | CA2402414A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | CA2401984A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | CA2401908A1 Amorphous torasemide modification |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136558A1 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136490A1 New forms of paroxetin hydrochloride |
| 09/26/2001 | EP1136482A1 2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors |
| 09/26/2001 | EP1136474A1 1-Acetyl-5-bromo-4,6-dimethyl-indoline |
| 09/26/2001 | EP1136071A2 Use of glycogen phosphorylase inhibitors |
| 09/26/2001 | EP1135998A1 Use of synthetic triglycerides based on conjugated linoleic acid as antioxydant in foodstuffs |
| 09/26/2001 | EP1135996A1 Use of synthetic triglycerides based on conjugated linoleic acid as colour stabilisor in foodstuffs |
| 09/26/2001 | EP1135677A1 In vivo biosensor apparatus and method of use |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135468A1 Virus vectors and methods of making and administering the same |
| 09/26/2001 | EP1135415A1 Humanized antibodies to gamma-interferon |
| 09/26/2001 | EP1135411A1 Methods and compositions for treating disorders involving excitotoxicity |
| 09/26/2001 | EP1135406A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3 |
| 09/26/2001 | EP1135389A1 1,4-diazabicyclo 3.2.2]nonane derivatives, their preparation and therapeutic application |
| 09/26/2001 | EP1135382A1 Method of producing paroxetine hydrochloride |
| 09/26/2001 | EP1135381A1 Eletriptan hydrobromide monohydrate |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors |
| 09/26/2001 | EP1135359A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135155A1 Methods of inhibiting ectopic calcification |
| 09/26/2001 | EP1135149A1 Pgc-1, a novel brown fat ppar gamma coactivator |
| 09/26/2001 | EP1135135A1 Chk1 kinase inhibitors |